Aspire Biopharma Holdings, Inc. (ASBP) Revenue (2025 - 2026)
Aspire Biopharma Holdings' Revenue was $63,104 in Q2 2026, up 122.6% from the prior quarter.
Powered by 
Analysis
Aspire Biopharma Holdings, Inc. (ASBP) Revenue (2025 - 2026) Analysis & Trends
On a trailing twelve-month basis, Aspire Biopharma Holdings' Revenue was $97,659 through Jun 30, 2026; for FY2025, it was $6,202.
- Per Business Quant data, ASBP's Revenue in the three quarters before Q2 2026 was $28,353 (Q1 2026), $4,261 (Q4 2025) and $1,941 (Q3 2025).
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 63,104.00 |
| Mar 31, 2026 | 28,353.00 |
| Dec 31, 2025 | 4,261.00 |
| Sep 30, 2025 | 1,941.00 |
API Access
Aspire Biopharma Holdings, Inc. Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ASBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ASBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ASBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();